Supplementary Note Dynamic light scattering (DLS)
In main Fig. 4 , the light source of DLS was a solid-state laser with an output of 100 mW and a wavelength of 533 nm. The intensities at scattering angles, , from 30 to 100° with a step of 10° were simultaneously measured using eight optical fibers connected to eight photodiodes. The accumulation time to complete each measurement was 240 s. The second autocorrelation function, g (2) (, t), at time t was measured for use in calculating the inverse decay time, , of a particle:
where K is an instrumental constant and i represents the i-th particle in the solution. The measurement was repeated consecutively four times in each run to estimate the error in The g
(, t) function was analyzed using an ALV-5000E correlation system. Both CONTIN and NNLS fittings were used to estimate  for each  to determine whether the results were independent of the analysis method. In the calculation of the intensity-percent and mass-percent fittings were compared to estimate the applicability.
The apparent translational particle diffusion coefficient, D, was calculated from the slope of the  vs. q 2 plot:
where q is the scattering vector related to , and wavelength , and solution refractive index n:
The hydrodynamic radius (particle radius), R H , was calculated using the Stokes-Einstein relationship:
where k B , T, and h are the Boltzmann constant, the absolute temperature of the solution, and the solution viscosity, respectively. The h was measured using a rolling-ball type viscometer (Lovis 2000M, Anton-Parr, Co. Ltd.)
Extraction of TGF- in enamel matrix
Three TGF- isoforms (TGF-1 to -3) have been identified in mammalian. Those isoforms possess over 97% of amino acid sequence homology within mature bioactive molecule 1 . Each of isoforms has also very high amino acid sequence among species (see Supplementary Fig. S2 ).
Certain consensus sequences have been proposed for heparin-binding proteins, such as BBXB or BXBB, where B denotes a positively charged amino acid residue 2 . We found that the mature TGF-1 possesses one heparin-binding site (R372-K375) conserved in mouse, rat, human and pig (see Supplementary Fig. S2 ), but not in the mature TGF- or TGF-. Based on this finding, we tried to isolate TGF- isoforms in both N1 and AL extracts with heparin affinity chromatography.
Identification of amelogenin-TGF-1 complex in vivo
The identification of TGF-1 in vivo was determined by ELISA. The fractions (10 g each) isolated by heparin column and each of purified P173, P162, P148 and P103 amelogenins (6.25
g each) was dissolved or suspended in 200 L of phosphate buffered saline (PBS), and aliquots (40 L each) were used for ELISA. The quantitative analysis for TGF-1 was carried out by using the calibration curve of serial dilutions of TGF-1 ranging from 0 to 2000 pg mL -1 (see Supplementary Fig. S6 ).
In this study, we qualitatively modified a sandwich ELISA to know if amelogenin cleavage products bind to TGF-1 in vivo. We first used the amelogenin antibody as the detection antibody as well as Western blot analysis, but the significant contamination (see Supplementary amelogenins reacted with the purified biotinylated-amelogenin and bound to a HRP-conjugated streptoavidin for the DAB detection (see Supplementary Fig. 7b ). We finally used this biotinylated-amelogenin antibody for detecting the amelogenin-TGF-1 complex by ELISA (see main Fig. 3e ).
Supplementary Method
Quantitative real-time PCR
Ameloblasts at three stages were extracted with RNA extraction reagent (Isogen, Nippon Gene
Co., Ltd., Tokyo, Japan). Following the purified total RNA (2 μg) was reverse transcribed, the reaction mixture consisted of SYBR Green PCR master mix (Roche), supplemented with 0.5 µM forward and reverse primers and 2 µL of cDNA as template. After an initial preheating step at 95 °C for 10 min, samples were run for 45 cycles (denaturation for 10 sec at 95 °C, annealing for 10 sec at 60 °C and extension for 15 sec at 72 °C). The specific primer sets were designed using Primer-BLAST software (URL: http://www.ncbi.nlm.nih.gov/tools/primer-blast). The selected primers were designed as TGF-1F, 5'-GCCTGCTGAGGCTCAAGTTA-3', paired and TGF-1 is shown in main Fig. 1b-d , while that of TGFBR1 is shown in main Fig. 5a .
Isolation of porcine kallikrein 4 (pKLK4)
3
The H-N2 extracts was fractionated by reversed-phase high-performance liquid chromatography (RP-HPLC) using a Discovery C18 column (4.6 mm x 25 cm, Sigma-Aldrich/Supelco, Bellefonte, PA, USA) and eluted with a linear gradient (20 to 80% B in 60 min) at a flow rate of 1.0 mL min
. Buffer A was 0.05% trifluoroacetic acid (TFA); buffer B was 0.1% TFA in 80% aqueous acetonitrile. Protein was detected by absorbance at 220 nm. The pKLK4 fraction eluted between 57 and 61 min, and was concentrated and buffer-exchanged to 50 mM Tris-HCl (pH 7.4) using an Amicon Ultra-4 Centrifugal Filter (Millipore Corporation). The KLK4 fraction was characterized by gelatin zymography (see Supplementary Method 3) and the protein content of the KLK4 fraction was measured using the Pierce 660 nm Protein Assay kit (Thermo Scientific, Rockford, IL, USA) and the sample was stored at -80 °C.
Enzymograms
To know the active form of purified pMMP-20 and pKLK4, zymography was carried out using Supplementary Fig. S1 .
Enzyme-linked immunosorbent assay (ELISA)
For ELISA, the fractions (10 µg each) isolated by heparin column and each of purified P173, P162, P148 and P103 amelogenins (6.25 µg each) was bound to TGF-1 capture antibody coated on the plate and was labeled by HRP-conjugated TGF-1 detection antibody. The quantitative analysis of TGF-1 was carried out based upon a calibration curve prepared from different concentrations of standard TGF-1 (see Supplementary Fig. S6 ) Each purified P173, P162, P148 and P103 amelogenin bound to TGF-1 capture antibody was labeled by the biotinylated amelogenin antibody (see Supplementary Fig. S7 ) as the detection antibody and HRP-conjugated streptavidin was subsequently added. The positive signal for TGF-1 or amelogenin-TGF-1 complex was detected using a tetramethylbenzidine (TMB) substrate.
In vitro binding experiments for amelogenin and TGF-1
Purified P173, P162, P148 and P103 amelogenins, TRAP and LRAP (0.5 mg each) were incubated with one µg of the carrier-free recombinant human TGF-1 (CF-hTGF-β1) (Cell Signaling Technology, Danvers, MA, USA) in 50 mM Tris-HCl buffer (pH 7.4) for 20 h at 37°C.
Each amelogenin was fractionated by RP-HPLC with the same system as their purification. ). The resulting data is shown in Supplementary Fig. S8 and main Table 1 .
In vitro binding experiments of latent TGF-1 and amelogenins
Purified P173 and P103 amelogenins (1 mg each) were incubated with 0.75 ng of rh-latent TGF-1 in 50 mM Tris-HCl and 10 mM CaCl 2 (pH 7.4) for 20 h at 37°C. The P173 and P103
amelogenins bound or unbound to rh-latent TGF-1 were fractionated by RP-HPLC and lyophilized. Each of samples was dissolved into 200 µL of water and an aliquot (50 µL) was used for the ALP-HPDL system. Amelogenins only were also incubated and fractionated by RP-HPLC as controls. The resulting data is shown in Supplementary Fig. S9 .
TGFBR1 kinase assay with TR-FRET
Three experiments for TGFBR1 kinase assay were performed by using a technique of LANCE Ultra TR-FRET. For ATP titration experiment, the TGFBR1 (10 µg) was incubated with 100 nM of ULight-Topo IIa (Thr1342) 
